Bristol-Myers Squibb
BMY
#199
Rank
$86.66 B
Marketcap
$42.76
Share price
3.77%
Change (1 day)
-30.87%
Change (1 year)

P/E ratio for Bristol-Myers Squibb (BMY)

P/E ratio as of July 2024 (TTM): 10.4

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.3778. At the end of 2022 the company had a P/E ratio of 24.1.

P/E ratio history for Bristol-Myers Squibb from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202224.122.82%
202119.7-226.77%
2020-15.5-153.28%
201929.169.66%
201817.2-82.64%
201798.8351.57%
201621.9-69.14%
201570.945.37%
201448.843.19%
201334.121.27%
201228.174.6%
201116.19.38%
201014.7211.7%
20094.72-46.82%
20088.87-63.53%
200724.3-26.05%
200632.9117.62%
200515.1-27.42%
200420.817.26%
200317.8-17.89%
200221.6-55.46%
200148.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
15.9 52.83%๐Ÿ‡บ๐Ÿ‡ธ USA
68.9 563.53%๐Ÿ‡บ๐Ÿ‡ธ USA
173 1,571.16%๐Ÿ‡บ๐Ÿ‡ธ USA
29.6 184.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
15.7 51.65%๐Ÿ‡ซ๐Ÿ‡ท France
39.6 281.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
10.7 3.31%๐Ÿ‡บ๐Ÿ‡ธ USA
46.0 342.97%๐Ÿ‡บ๐Ÿ‡ธ USA
23.5 126.86%๐Ÿ‡บ๐Ÿ‡ธ USA
12.2 17.46%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.